These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 245293)

  • 1. Parkinson's disease.
    Taylor J
    Aust Nurses J; 1977 Nov; 7(5):27. PubMed ID: 245293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of parkinsonism].
    Parkenberg H
    Ugeskr Laeger; 1976 Apr; 138(18):1104-5. PubMed ID: 1265907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
    Benesová O
    Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

  • 5. Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.
    Butzer JF; Silver DE; Sahs AL
    Neurology; 1975 Jul; 25(7):603-6. PubMed ID: 807867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of parkinsonian tremor.
    Koller WC
    Arch Neurol; 1986 Feb; 43(2):126-7. PubMed ID: 3947248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to achieve maximum benefit for the patient with Parkinson's disease.
    Greer M
    Geriatrics; 1976 Apr; 31(4):89-96. PubMed ID: 4356
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug therapy of parkinsonism.
    Bianchine JR
    N Engl J Med; 1976 Oct; 295(15):814-8. PubMed ID: 958277
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between desipramine plasma levels and the effect in Parkinson's syndrome.
    Muscettola GB; Giovannucci M; Montanini R; Morselli PL; Garattini S
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):375-9. PubMed ID: 5079227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
    Dzudza M; Dzudza D
    Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment with L-dopa and amantadine in Parkinson's disease.
    Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
    Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of neurologic disorders in the elderly.
    Mancall EL; Covington TR; Alonso RJ
    Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the management of parkinson's disease.
    Marsden CD
    Scott Med J; 1976 Jul; 21(3):139-48. PubMed ID: 781839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-O-Methyldopa in Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Adv Neurol; 1974; 5():309-15. PubMed ID: 4440579
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP; Kunz F; Lörincz P; Ringwald E
    Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa-induced myoclonus.
    Klawans HL; Goetz C; Bergen D
    Arch Neurol; 1975 May; 32(5):330-4. PubMed ID: 1079721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.